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INTRODUCTION
The prevalence of type 2 diabetes increases with age and
the disease is common in the elderly. By the age of 75, up to
20% of the population has diabetes (1). Moreover, undiag-
nosed diabetes according to fasting glucose-based WHO
criteria, so called, isolated postchallenge hyperglycemia (IPH)
are also common in the elderly. IPH in undiagnosed elderly
diabetic women is related with a risk of fatal cardiovascular
disease (2). Despite the high prevalence and mortality of
elderly diabetes, few studies have examined the alterations
in the glucose metabolism. Meneilly et al. reported that lean
elderly type 2 diabetic patients had a profound impairment
in glucose-induced insulin release and mild resistance to
insulin-mediated glucose disposal, but obese patients were
the opposite (3).
In contrast to Caucasians or other high risk populations,
non-obese type 2 diabetics are more common in the Korean
population (4) and insulin secretory capacity of Korean peo-
ple is smaller than the western people so that they cannot
compensate for the insulin resistance imposed by recent
changes in life style (5). However, little is known regarding
the impairment in carbohydrate metabolism in Korean lean
elderly type 2 diabetic patients.
This study was conducted to assess insulin release and sen-
sitivity characteristics in lean elderly Korean women with
glucose tolerance abnormalities during oral glucose tolerance
test (OGTT).
MATERIALS AND METHODS
Study subjects and Measurements
A total of 73 elderly women at Soonaewon, an institution
for the aged, located in Kyung-gi province were enrolled.
Subjects with a body mass index (BMI) greater than 25 kg/m2
were excluded. They were either not known to have diabetes
(n=63) or with type 2 diabetes (n=10) controlled with oral
hypoglycemic agents or diet control only, with disease dura-
tion of 5-14 yr. Their ages ranged from 65 to 88 yr. The par-
ticipants were nonsmokers (never smoked or quitted over 5
yr ago). Subjects were excluded if they had significant under-
lying diseases other than hypertension and had evidence of
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Insulin Secretion and Sensitivity during Oral Glucose Tolerance Test
in Korean Lean Elderly Women
Impaired glucose tolerance (IGT) and type 2 diabetes including undiagnosed iso-
lated postchallenge hyperglycemia (IPH) are common in the elderly. The aim of
this study was to investigate the insulin secretion and sensitivity in Korean elderly
lean diabetic women. Forty-one lean women aged 65-88 years took 2 hr oral glu-
cose tolerance test (OGTT) and were stratified according to the WHO criteria
(normal glucose tolerance [NGT], n=20; IGT, n=6; and type 2 diabetics, n=15
including seven IPH). HbA1c and fructosamine progressively increased from the
NGT to the diabetic subjects (p=0.006 and p=0.001, respectively). Compared
with subjects with NGT, the insulinogenic index, a marker of early insulin secre-
tion and the AUCins, a marker of total insulin secretion, decreased significantly in
diabetic group [0.53 (-0.44 -1.45) vs. 0.18 (0.00 -1.11), p=0.03 and 306±165 vs.
199±78 pmol/L, p=0.02 respectively]. A significant difference was found in the
AUCc-peptide among each group (221±59 vs. 206±34 vs. 149±51 pmol/L,
p=0.001 for each). The homeostasis model assessment of insulin resistance
(HOMA-IR), a marker of insulin resistance, was not different among the groups.
We conclude that compared with NGT subjects, elderly lean women with dia-
betes have impaired oral glucose-induced insulin secretion but have relatively
preserved insulin sensitivity. This suggests that insulin resistance is not neces-
sarily an essential component of Korean elderly lean diabetic women. 
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complications from type 2 diabetes. All of them were ambu-
latory, and none of them had acute cardiovascular or cere-
brovascular diseases, nor were taking any medications known
to interfere with glucose tolerance such as glucocorticoid or
salicylate. Of the 10 type 2 diabetic patients, 6 were being
treated with oral hypoglycemic agents and none had ever
been treated with insulin.
Body weight and height were measured while subjects
wore light clothing without shoes and BMI was calculated.
Samples for the measurement of HbA1c, total cholesterol,
triglyceride, LDL-cholesterol, and HDL-cholesterol were
drawn after an overnight fast. A standard (75 g) OGTT was
performed in all of the study subjects. Diabetic subjects
stopped taking oral hypoglycemic agents for 3 days. All
consumed a diet containing at least 200 g carbohydrate for
3 days before the tests. After a overnight fast, an antecubital
intravenous line was inserted and the subjects ingested com-
mercially-available OGTT solution (DiasolR, Taejoon Phar-
maceuticals, Seoul, Korea) within 2 min. Blood samples for
the determination of plasma glucose, insulin, and C-peptide
levels were drawn at 0, 30, 60, 90, and 120 min after solu-
tion ingestion.
The insulinogenic index was provided to represent early
insulin response. It was calculated as the ratio of increment
of insulin to that of blood glucose 30 min after glucose load
(30 min insulin level-fasting insulin level [IU/mL]/30 min
plasma glucose-fasting plasma glucose (FPG) [mg/dL]) (6).
The area under the insulin and C-peptide curve (AUCins,
AUCc-peptide), a marker of total insulin secretion, was calculat-
ed using the trapezoidal rule as the total area under the insulin
and C-peptide response curve during the 2 hr OGTT.
The homeostasis model assessment of insulin resistance
(HOMA-IR), a marker of insulin resistance, was calculated
as FPG (mmol/L)×fasting plasma insulin ( IU/mL)/22.5
(8). We also adopted Quantitative Insulin Sensitivity Check
Index (QUICKI=1/[log (fasting plasma insulin ( U/mL))
+log (FPG (mg/dL))]) as an another index of insulin sensi-
tivity (9).
Assays
Fasting, 30, 60, 90, and 120 min venous plasma glucose
during OGTT were determined immediately on site with a
YSI glucose analyzer (Yellow Springs, Ohio, U.S.A.). Plas-
ma was stored at -70℃until assayed. 
Specific insulin concentration was determined by radioim-
munoassay (RIA) using a human-specific antibody (human
insulin specific RIA kit, Linco Research, St. Charles, MO,
U.S.A.), which does neither cross-react with human proin-
sulin (<0.02%) nor primary circulating split form, des 31,
32 proinsulin. C-peptide concentration was determined by
RIA using a Human C-peptide RIA kit (Linco Research,
St. Charles, MO, U.S.A.), which has very low cross-reactivi-
ty (<4.0%) to human proinsulin.
Concentrations of total cholesterol and triglyceride were
determined by enzymatic method using an automatic ana-
lyzer (Hitachi 7150, Naka, Japan). HDL-cholesterol was
determined by an electrophoretic method using an HDL-
cholesterol Supply Kit (Helena Laboratory, Beaumont, TX,
USA) and LDL-cholesterol level was calculated. HbA1c was
measured with high-performance liquid chromatography
(HPLC) and fructosamine with a standard enzyme method.
Statistical analysis
Results are expressed as means±SD or as medians and
minimum-maximum intervals when the distribution is non-
parametric. Physical and biochemical variables were com-
pared by unpaired t tests, one-way analyses of variance
(ANOVA) or repeated measures ANOVA. Non-normally
distributed data were compared using the Mann-Whitney
U test or Kruskal Wallis test for independent samples. A 2-
tailed p value <0.05 was considered signigicant. Statistical
analyses were performed using SPSS for Windows, version
9.0 (SPSS, Chicago, U.S.A.).
RESULTS
Glucose tolerance and clinical characteristics
Of the total 73 individuals who initially underwent OGTT,
only 41 were enrolled as study subjects because 12 individ-
uals were excluded on the basis of inadequate lipid profile,
and 20 were excluded on the basis of sample collection error
due to vulnerable vein. Classifications of subjects were based
on the World Health Organization (WHO) diagnosis of
diabetes criteria using fasting and 120 min plasma glucose
(7): [1] impaired glucose tolerance (IGT) was defined as
FPG <7.0 mmol/L and 7.8 mmol/L ≤2-hr plasma glucose
(2h-PG) <11.1 mmol/L; [2] diabetes was defined as FPG
≥7.0 mmol/L or 2 hr-PG ≥11.1 mmol/L. The diagnosis
of known type 2 diabetes (KD) was based on a previous his-
tory of diabetes or WHO criteria and IPH was defined as
FPG <7.0 mmol/L and 2 hr-PG ≥11.1 mmol/L according
to other reference (2).
Amongst the 41 subjects, 20 showed normal glucose tol-
erance (NGT), 6 had IGT, and 15 were diabetics (7 were ini-
tially detected as IPH and 8 were KD). The known duration
of diabetes ranged from 2 to 12 yr, with a mean of 5.3±2.7
yr. None had FPG over 126 mg/dL and impaired fasting
glucose state. 
Table 1 gives the subjects’ characteristics according to the
different groups. There was no difference in age, systolic
and diastolic blood pressure, BMI, and lipid profiles among
3 groups. The FPG increased progressively from the NGT
to the type 2 diabetic subjects (p=0.016). Two-hour PG,
HbA1c, and fructosamine progressively increased from the594 J. Kim, S. Choi, B. Kong, et al.
NGT to the diabetic subjects (p=0.001, p=0.006, p=0.001,
respectively for trend).
Insulin secretion
Fig. 1 shows the glucose, insulin, and C-peptide responses
during OGTT in 3 groups. Significant differences were found
in the AUCglucose and AUCc-peptide, in all groups, respectively
(p<0.001 and p<0.01). p value was 0.02 for the difference
in AUCins in subjects with NGT vs. diabetic group. Com-
pared with subjects with NGT, the insulinogenic index
decreased significantly in diabetic group (p=0.03) (Table 1).
If the diabetic group is further divided into IPH and KD
groups, insulinogenic index were not significantly different
among 4 groups [0.53 (-0.44-1.45) vs. 0.23 (0.01-0.44) vs.
0.18 (0.08-0.44) vs. 0.21 (0.00-1.11), p=0.14), but lower in
IPH than NGT group with borderline significance (p=
0.06). The AUCins was significantly lower in KD group than
n 20 6 15
Age (yr) 80.4±6.0 75.7±5.7 78.9±7.2
BMI (kg/m
2) 20.8±2.8 19.8±2.1 21.0±2.9
Blood pressure (mmHg)
Systolic 128±18 135±24 124±23
Diastolic 75±87 5 ±10 73±12
Cholesterol (mmol/L) 4.96±1.04 5.05±0.68 4.78±1.10
LDL cholesterol (mmol/L) 2.91±1.03 3.11±0.71 2.66±1.06
Triglyceride (mmol/L) 1.28 1.21 1.08
(0.51-7.68) (0.85-2.24) (0.67-5.00)
HDL cholesterol (mmol/L) 1.15 1.11 1.03
(0.72-1.58) (0.85-1.37) (0.70-2.20)
FPG (mmol/L)* 5.01±0.53 5.07±0.33 5.60±0.72
2-h PG (mmol/L)
� 7.47±1.69 8.99±2.22 12.89±3.32
HbA1c (%)
� 6.41±0.37 6.65±0.34 6.89±0.48
Fructosamine (umol/L)
� 211.8±14.9 241.8±19.4 259.9±35.8
Fasting insulin (pmol/L) 50.7 45.6 55.8
(19.2-112.2) (20.4-65.4) (36.0-82.2)
Fasting C-peptide (nmol/L) 0.44 0.31 0.23
(0.12-0.99) (0.22-0.61) (0.09-0.83)
Insulinogenic index 0.53 0.23 0.18
�
(-0.44-1.45) (0.01-0.44) (0.00-1.11)
AUCins (pmol/L) 306±165 265±82 199±78
�
AUCc-peptide (pmol/L)
� 221±59 206±34 149±51
HOMA-IR 2.11±1.13 1.66±0.64 2.32±0.58
QUICKI 0.35±0.03 0.36±0.02 0.34±0.01
Table 1. Clinical and laboratory data of subjects
Group  NGT IGT
Type 2 diabetes
(KD and IPH)
NGT; normal glucose tolerance, IGT; impaired glucose tolerance, KD;
known type 2 diabetes, IPH; isolated postchallenge hyperglycemia,
BMI; body mass index, LDL-Cholesterol; low density lipoprotein
cholesterol, HDL-Cholesterol; high density lipoprotein cholesterol,
FPG; fasting plasma glucose, 2 hr PG; 2 hr postprandial glucose,
AUCins; area under the insulin curve, AUCc-peptide; area under the C-
peptide curve, HOMA-IR; homeostasis model assessment of insulin
resistance, QUICKI; quantitative insulin sensitivity check index.
Data are means±SD, or medians (range). *p<0.05 for trend; 
� p<0.01
for trend; 
� p<0.05 vs. NGT.
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Fig. 1. Comparison of plasma glucose, insulin, and C-peptide
levels during OGTT in 3 groups. All values are mean±SEM.
p<0.001 and p<0.01 for the differences in glucose and C-pep-
tide area in each group, respectively. p<0.05 for the difference
in insulin area in subjects with NGT vs. diabetic group. Insulin Secretion and Sensitivity in Korean Lean Elderly Women 595
NGT group (306±165 vs. 169±72 pmol/L, p=0.018). The
AUCc-peptide decreased progressively from NGT to KD group
(NGT; 221±59 vs. IGT; 206±34 vs. IPH; 177±35 vs.
KD; 124±52 pmol/L, p=0.002).
Insulin sensitivity
Fig. 2 shows HOMA-IR and QUICKI in 3 groups. The
HOMA-IR was not different among the groups (p=0.18). The
QUICKI was not different among the groups, either
(p=0.18). When the diabetic group is divided into IPH and
KD groups, HOMA-IR and QUICKI were not significant-
ly different among 4 groups (HOMA-IR; 2.11±1.13 vs.
1.66±0.64 vs. 2.38±0.58 vs. 2.27±0.61, p=0.31, QUIC-
KI; 0.35±0.03 vs. 0.36±0.03 vs. 0.34±0.01 vs. 0.34±
0.01, p=0.32).
DISCUSSION
This study was performed to compare the dynamics of
glucose metabolism among elderly lean women with NGT,
IGT, and type 2 diabetes. Our data show that insulin secre-
tion is diminished in elderly lean women with IGT and
diabetes (including IPH), while insulin resistance was not
different in IGT or diabetic group compared with NGT
group.
Healthy elderly have higher glucose levels during OGTT,
as well as delayed glucose disappearance, than healthy young
subjects (10). There is a high prevalence of both diabetes
and IGT among the elderly and by the age of 75, approxi-
mately 40% of the population is affected with IGT or dia-
betes (11). Approximately one-third of these people were
undiagnosed prior to testing. Because of the known age-relat-
ed changes in carbohydrate metabolism, including dimin-
ished insulin release and resistance to insulin-mediated glu-
cose disposal (12, 13), it is expected that metabolic alteration
may be different in the elderly type 2 diabetic patients (14,
15). Meneilly et al. (3) reported lean elderly diabetics have a
profound impairment in glucose-induced insulin release but
have minimal resistance to insulin-mediated glucose disposal.
Our study shows that in lean elderly diabetic subjects, early
and total insulin secretion during OGTT were impaired. It
is interesting that acute phase of oral glucose-stimulated
insulin secretion was impaired in diabetic group compared
with NGT group. In IGT group, early insulin response
appears to decrease compared with NGT group but this
trend is not statistically significant. This suggests that loss
of early insulin secretion may be a characteristic finding in
the progression of IGT toward diabetes in the lean elderly.
The insulin assay in our study rarely cross-reacts with
proinsulin. It is known that the level of proinsulin increases
in diabetics and with aging (16). This suggests that it is
necessary to employ a highly specific insulin assay during
OGTT in the elderly.
In relation to the diagnosis of diabetes, there is evidence
that there is much proportion of previously undiagnosed
diabetic people with IPH and this proportion becomes larg-
er with increasing age. The risk of fatal cardiovascular dis-
ease and heart disease is doubled in elderly women with IPH
(2, 17). Previously we performed OGTT in 126 presumably
non-diabetic elderly women at Soonaewon and found unex-
pectedly high proportion of undiagnosed IPH (n=17, 13.5%).
Among the total of 26 elderly subjects who were newly-
diagnosed diabetics, 65.4% were IPH and this proportion
is similar to that in other report (2). The use of fasting glu-
cose alone for screening or diagnosis of diabetes may fail to
identify most elderly at high risk for cardiovascular disease
and should be reevaluated. In this study, when we divide
the diabetes group into KD and IPH groups, early insulin
response was decreased in IPH group than in NGT group
with borderline significance and AUCc-peptide, a marker of
total insulin secretion, in IPH group was between IGT and
KD groups. This probably means that IPH is the transition
phase from IGT to fasting glucose-based diabetes state.
The assessment of in vivo insulin sensitivity in humans
has been frequently based on the use of the glucose clamp
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Fig. 2. Comparison of HOMA-IR and QUICKI in 3 groups. All val-
ues are mean±SEM. No significant differences were observed
among groups.596 J. Kim, S. Choi, B. Kong, et al.
technique (18). This technique is considered the  “gold stan-
dard”(19) but this technique is not suited for large-scale
studies because of its complexity and high cost. An attrac-
tive approach to estimate insulin sensitivity using fasting
blood sample was developed by Matthews et al. (8) and Katz
et al. (9). Emoto et al. (20) and Bonora et al. (21) compared
HOMA-IR and the glucose clamp technique in type 2 dia-
betics and found a good correlation between the two meth-
ods. We used these estimates of insulin sensitivity and found
that HOMA-IR and QUICKI were not different among the
groups. There are some documented instances that shows
type 2 diabetes developed in nonobese subjects in the absence
of insulin resistance (22). Additional work awaits whether
type 2 diabetes can develop in lean elderly women without
aggravation of insulin resistance using an standard method
(glucose clamp study).
We admit that there are some limitations in this study.
One is that the number of study subjects is too small. With
the limited size of our study population, small differences
among groups could have been missed. The second is the
probable lack of reproducibility, because gastic emptying is
delayed and variable in the  elderly. Further studies are need-
ed to investigate the insulin secretion and sensitivity in elder-
ly Koreans using glucose clamp study. The hyperglycemic
clamp provides accurate measurements of insulin sensitivity
and secretion in the elderly (23) and we are now performing
hyperglycemic clamp studies to measure insulin secretion
more precisely and accurately in these study groups. The
third is the poor representativeness of the subjects, because
they were not randomly selected. Finally, we need to point
that cross-sectional design of this study makes it difficult to
conclude that insulin secretion decreases progressively with
advancing age and glucose intolerance. Nevertheless, as we
know, this is the first study on insulin secretion and sensi-
tivity during OGTT using sensitive insulin assay method
in elderly oriental women.
We conclude that compared with NGT subjects, elderly
lean women with diabetes have impaired oral glucose-induced
insulin secretion, including early insulin release but have
relatively preserved insulin sensitivity. This suggests  that
insulin resistance is not necessarily an essential component
of Korean elderly lean diabetic women. In this regard, efforts
to improve  -cell function and insulin administration may
be of prime concern in the treatment of patients in whom
impaired insulin secretion is the main problem, as in our
study subjects.
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